Participate in Research

Browse Clinical Trials
Clinical Study for People Diagnosed with Parkinson’s Disease
Protocol: STUDY00008239
Full Title
Repurposing lithium as a disease-modifying therapy in Parkinson's disease: a randomized controlled trial.
Description
The University at Buffalo (UB) Department of Neurology is recruiting adults diagnosed with Parkinson’s Disease (PD) for a new clinical research study. The goal of the study is to see if lithium (a medication that can be taken by mouth) can help to slow the progression of PD.

Participants will be enrolled in the study for about 24 weeks. They will be randomly assigned (which happens by chance, like flipping a coin) to receive either the study drug (lithium) or a control (which looks like the study drug but does not contain any active medication).

They will complete three in-person study visits to the UBMD Neurology Clinic in Williamsville and receive an MRI scan of their head at the beginning and end of the 24-week treatment period. They will also complete blood draws, physical exams, and surveys throughout the study.
Compensation: No
Eligibility
-Adults aged 45 to 80 years old
-Have been diagnosed with Parkinson's Disease (PD) for less than 4 years
-Not currently pregnant
-Have never taken prescription or over-the-counter lithium
-Speak English
Age Group: Adults
Principal Investigator: THOMAS GUTTUSO
Contact(s)
Amelia Cheney
acheney4@buffalo.edu

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login